Casey Connors suffers from recessive dystrophic epidermolysis bullosa (EB) and has to endure painful bandage changes that can ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

A brave young girl battling a horrendous skin condition is excited ahead of going to secondary school. Casey Connors suffers ...

A DUBLIN SCHOOLGIRL with the most severe form of a genetic skin condition is preparing to begin secondary school. Clondalkin ...

Krystal Biotech's VYJUVEK sees strong growth with $1B+ 2025 sales forecast. Check out why I rate KRYS as a Strong Buy and my ...

While recruitment and regulation are improving, they remain pain points, say speakers at Arena International’s OCT West Coast ...

South Side-based biotechnology firm Krystal Biotech Inc.'s stock is up 20% following its earnings call this morning.

Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe skin disorders, to Theravia, a pharmaceutical company headquartered in the ...

Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023 Full year revenues increased 473% to $290.5 million versus 2023 CFF TDN granted full sanctioning of KB407 Phase ...

Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023Full year revenues increased 473% to $290.5 million versus ...